Nbt Bank N A Novartis Ag Transaction History

Nbt Bank N A

$1.44 Billion
Q2 2025

A detailed history of Nbt Bank N A transactions in Novartis Ag stock. As of the latest transaction made, Nbt Bank N A holds 28,719 shares of NVS stock, worth $3.76 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

28,719

Previous 29,238 1.78%

Holding current value

$3.76 Million

Previous $3.26 Million 6.63%

% of portfolio

0.24%

Previous 0.24%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 23, 2025	SELL	$101.96 - $121.01 $52,917 - $62,804	-519 Reduced 1.78%	28,719 $3.48 Million
Q1 2025 Apr 17, 2025	SELL	$97.14 - $115.57 $135,218 - $160,873	-1,392 Reduced 4.54%	29,238 $3.26 Million
Q4 2024 Feb 07, 2025	SELL	$96.78 - $117.18 $162,106 - $196,276	-1,675 Reduced 5.18%	30,630 $2.98 Million
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $89,679 - $102,152	-845 Reduced 2.55%	32,305 $3.72 Million
Q2 2024 Jul 30, 2024	BUY	$92.57 - $107.37 $661,597 - $767,373	7,147 Added 27.49%	33,150 $3.53 Million
Q1 2024 Apr 24, 2024	SELL	$95.27 - $108.47 $30,867 - $35,144	-324 Reduced 1.23%	26,003 $2.52 Million
Q4 2023 Feb 09, 2024	SELL	$92.27 - $101.54 $28,419 - $31,274	-308 Reduced 1.16%	26,327 $2.66 Million
Q3 2023 Oct 26, 2023	BUY	$94.73 - $105.13 $617,450 - $685,237	6,518 Added 32.4%	26,635 $2.71 Million
Q2 2023 Jul 24, 2023	SELL	$92.52 - $104.91 $18,041 - $20,457	-195 Reduced 0.96%	20,117 $2.03 Million
Q1 2023 May 02, 2023	SELL	$80.03 - $92.81 $19,207 - $22,274	-240 Reduced 1.17%	20,312 $1.87 Million
Q4 2022 Feb 10, 2023	SELL	$75.55 - $92.52 $106,601 - $130,545	-1,411 Reduced 6.42%	20,552 $1.86 Million
Q3 2022 Nov 08, 2022	SELL	$74.61 - $87.26 $10,072 - $11,780	-135 Reduced 0.61%	21,963 $1.67 Million
Q1 2022 Apr 29, 2022	SELL	$80.11 - $90.62 $37,411 - $42,319	-467 Reduced 2.07%	22,098 $1.94 Million
Q4 2021 Jan 27, 2022	SELL	$79.7 - $88.13 $24,866 - $27,496	-312 Reduced 1.36%	22,565 $1.97 Million
Q3 2021 Oct 18, 2021	SELL	$81.78 - $95.14 $4,089 - $4,757	-50 Reduced 0.22%	22,877 $1.87 Million
Q2 2021 Jul 28, 2021	SELL	$85.24 - $94.15 $31,453 - $34,741	-369 Reduced 1.58%	22,927 $2.09 Million
Q1 2021 Apr 08, 2021	SELL	$83.5 - $98.47 $62,625 - $73,852	-750 Reduced 3.12%	23,296 $1.99 Million
Q4 2020 Jan 15, 2021	SELL	$78.07 - $94.43 $16,550 - $20,019	-212 Reduced 0.87%	24,046 $2.27 Million
Q3 2020 Oct 29, 2020	SELL	$82.14 - $91.0 $25,545 - $28,301	-311 Reduced 1.27%	24,258 $2.11 Million
Q2 2020 Jul 22, 2020	SELL	$80.93 - $91.1 $202,163 - $227,567	-2,498 Reduced 9.23%	24,569 $2.15 Million
Q1 2020 Apr 23, 2020	SELL	$70.67 - $99.01 $48,550 - $68,019	-687 Reduced 2.48%	27,067 $2.23 Million
Q4 2019 Feb 05, 2020	SELL	$84.35 - $95.37 $31,209 - $35,286	-370 Reduced 1.32%	27,754 $2.63 Million
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $15,995 - $17,626	-187 Reduced 0.66%	28,124 $2.44 Million
Q2 2019 Aug 07, 2019	SELL	$75.4 - $92.8 $104,655 - $128,806	-1,388 Reduced 4.67%	28,311 $2.59 Million
Q1 2019 May 06, 2019	SELL	$75.32 - $86.15 $11,825 - $13,525	-157 Reduced 0.53%	29,699 $2.86 Million
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $163,009 - $181,510	-2,213 Reduced 6.9%	29,856 $2.56 Million
Q3 2018 Nov 09, 2018	SELL	$66.94 - $77.43 $182,947 - $211,616	-2,733 Reduced 7.85%	32,069 $2.76 Million
Q2 2018 Jul 31, 2018	SELL	$64.91 - $73.36 $192,458 - $217,512	-2,965 Reduced 7.85%	34,802 $2.63 Million
Q1 2018 May 22, 2018	SELL	$70.39 - $84.15 $39,066 - $46,703	-555 Reduced 1.45%	37,767 $3.05 Million
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $91,714 - $98,447	-1,268 Reduced 3.2%	38,322 $3.22 Million
Q3 2017 Nov 07, 2017	SELL	$74.14 - $77.27 $59,163 - $61,661	-798 Reduced 1.98%	39,590 $3.4 Million
Q2 2017 Aug 08, 2017	BUY	N/A	40,388	40,388 $3.37 Million

Others Institutions Holding NVS

# of Institutions

1,561

Shares Held

136M

Call Options Held

1.72M

Put Options Held

1.7M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $281B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbt Bank N A , based on Form 13F filings with the SEC.

News

Stay updated on Nbt Bank N A with notifications on news.

Account